Skip to main content
Premium Trial:

Request an Annual Quote

NIGMS Sets Aside $7M in FY 2009 to Create Two National Systems Biology Centers

NEW YORK (GenomeWeb News) – The National Institute of General Medical Sciences has set aside $7 million in fiscal year 2009 to create two National Centers for Systems Biology.
According to a request for applications issued last week, NIGMS the centers will conduct studies into a variety of areas of systems-level research. Applicants for the program may request up to $2 million per year in direct costs for up to five years.
In the RFA, NIGMS defined systems biology as “an integrated experimental, informational, and computational science” that has “benefited from advances in genomics, proteomics, metabolomics, and other high-throughput technologies and is driven by innovations in computational analysis and simulation.”
NIGMS said that systems biology provides a wealth of new knowledge in many areas of biomedical research, but there are “significant conceptual, technological, and cultural challenges to the realization of the systems biology goals.”
The purpose of the program, NIGMS said, is “to promote innovative responses to these challenges.” 
NIGMS expects the centers to promote communication, collaboration, and technology and data sharing, and to develop continuous communication and feedback between experimental and theoretical researchers.
NIGMS said the systems biology centers will study synthetic biology systems, multi-scale modeling approaches, signaling, genetic, and metabolic networks, and genetic variations in relation to complex phenotypes.  

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.